The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwCLL 2019 | CLL biology and patient stratification
Thomas Kipps, MD, PhD, from University of California San Diego, San Diego, CA, Barbara Eichhorst, MD, from University Hospital Cologne, Cologne, Germany, and Arnon Kater, MD, PhD, from the University of Amsterdam, Amsterdam, The Netherlands, discuss the highlights of the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK. The speakers discuss new insights into the biology of chronic lymphocytic leukemia (CLL) and their use in patient stratification and the development of treatment algorithms.
